Johnson & Johnson today announced that its affiliate Janssen Therapeutics, Division of Janssen Products, LP , has signed a Memorandum of Understanding representing the intention of the Company along with the United States Agency for International Development to step up the fight against the health threat of antibiotic-resistant bacteria. Antimicrobial resistance and specifically that seen in multidrug-resistant tuberculosis is one of the world's most serious public health threats.